|
| Merck will help make Johnson & Johnson’s one-shot COVID-19 vaccine. The unusual deal between rivals was brokered by the White House and will be announced later today by President Joe Biden. Merck will dedicate two facilities in the U.S. to J&J’s vaccine as part of the arrangement, with one faci... |
| Jounce Therapeutics Inc (NASDAQ: JNCE): Jounce Therapeutics shares have gained 17% over the last week following the announcement of the clinical-stage biotech’s fiscal fourth quarter results. “2020 proved to be a year of important pipeline execution and corporate development at Jounce despite the challenges presented by the COVID-19 pandemic. As we enter 2021, we are strongly p... |
CVS is a bargain the broad market isn’t paying attention toLooking for value in the stock market is something that I contend you can do in any market condition, but it is something that tends to get dismissed by most pundits simply because it isn’t very sexy. Names like Tesla, Netflix, and Amazon practically never make the value list because the massive amount of attention the market has given them for years has kept their stocks priced at levels that makes them impractical to consider strictly on the basis of value. Instead, current market conditi... |
| |
|
|
| Aclaris Therapeutics, Inc., a biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. It operates in two segments, Therapeutics and Contract Research. The company offers ESKATA, a formulation of high-concentration hydrogen peroxide topical solution for raised seborrheic keratosis, a common non-malignant skin tumor. Read More |
| |
Trend Following PicksAll Picks |
Reversal PicksAll Picks |
Already subscribed to our premium service?Click here to Login.Not a TradersPro subscriber yet?Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits |
| This email was sent to phanhoa1821960.trader@blogger.com Unsubscribe or Mange which emails you get from TradersPro Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. |
No comments:
Post a Comment